Chapter 1. PREVENTIVE THERAPY MARKET – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. PREVENTIVE THERAPY MARKET – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

 2.3.1. Impact during 2023 - 2030

  2.3.2. Impact on Supply – Demand

Chapter 3. PREVENTIVE THERAPY MARKET –  Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. PREVENTIVE THERAPY MARKET - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. PREVENTIVE THERAPY MARKET -  Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. PREVENTIVE THERAPY MARKET – By Early Detection and Screening Technology

6.1. Personalized Medicine

6.2. Prophylaxis Technologies

6.3. Automated Screening

6.4. Others

Chapter 7. PREVENTIVE THERAPY MARKET – By Prophylaxis Technology:

7.1. Influenza Vaccines

7.2. Combined Diphtheria-Tetanus-Pertussis (DTP) Vaccines

7.3. Human Papillomavirus (HPV) Vaccine

7.4. Meningococcal Vaccines

7.5. Other Vaccines

Chapter 8. PREVENTIVE THERAPY MARKET – By Advanced Technology

8.1. Automated Prescription, Formulation and Dispensing

8.2. Clinical Decision Support System

8.3. Computerized Provider Order Entry Systems

8.4. Electronic Prescribing Systems

8.5. Smart Infusion Pumps

8.6. Smart Packaging

Chapter 9. PREVENTIVE THERAPY MARKET – By Chronic Disease Management Technology

9.1. Asthma Monitors

9.2. Blood Pressure Monitors

9.3. Cardiac Monitors

9.4. Glucose Monitors

Chapter 10. PREVENTIVE THERAPY MARKET – By Region

10.1. North America

10.2. Europe

10.3. Asia - Pacific

10.4. Latin America

10.5. The Middle East

10.6. Africa

Chapter 11. PREVENTIVE THERAPY MARKET – By Companies

11.1. Company 1

11.2. Company 2

11.3. Company 3

11.4. Company 4

11.5. Company 5

11.6. Company 6

11.7. Company 7

11.8. Company 8

11.9. Company 9

11.10. Company 10